Diabetes 2014;63:12241233.ArticlePubMed 81
Sources Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies Diabetes, Obesity and Metabolism, Neeland et al., 2024 Muscle Mass and Glucagon-Like Peptide-1 Receptor Agonists: Adaptive or Maladaptive Response to Weight Loss
Some tirzepatide users notice that their tolerance to caffeine shifts as they eat and drink less
By doing so, we help patients achieve results that improve their long-term health and quality of life
It generally has a half-life (how long it takes your body to clear 50% of the substance from your system) of around five hours, though this varies substantially
economists constantly measure it, applauding when it goes up, worrying when it goes down